Correspondence to the Lancet two weeks ago revealed another instance in which clinical research studies that failed to provide results favor...
Home » Posts filed under GlaxoSmithKline
Showing posts with label GlaxoSmithKline. Show all posts
Showing posts with label GlaxoSmithKline. Show all posts
Monday, May 18, 2015
Sunday, May 17, 2015
More Evidence for Suppression of Research: the Case of Lamictal for Depression
We recently discussed the severe challenges to evidence-based medicine presented by manipulation and suppression of clinical research to ...
More Evidence for Suppression of Research: the Case of Lamictal for Depression
Rating: 4.5
Diposkan Oleh:
Unknown
Wednesday, May 13, 2015
Bring Back the DSI*? - the Avandia Case as Spy Novel
Starting in 2007, we posted quite a bit about the "Avandia case," which centered on whether Avandia (rosiglitazone, by GlaxoSmithK...
Bring Back the DSI*? - the Avandia Case as Spy Novel
Rating: 4.5
Diposkan Oleh:
Unknown
Tuesday, May 12, 2015
Quis Custodiet Ipsos Custodes?
HAPPY TIMES AT NIMH Two weeks ago I discussed a Commentary in JAMA by Dr. Thomas Insel, Director of the National Institute of Mental Heal...
Quis Custodiet Ipsos Custodes?
Rating: 4.5
Diposkan Oleh:
Unknown
Thursday, May 7, 2015
The Avandia Spin Cycle Continues Even After the FDA Safety Hearings
We have posted multiple times about Avandia (rosiglitazone), GlaxoSmithKline's star-crossed glucose-lowering drug. While Avandia has re...
The Avandia Spin Cycle Continues Even After the FDA Safety Hearings
Rating: 4.5
Diposkan Oleh:
Unknown
Friday, August 21, 2009
Another Haunting Tale
Halloween is more than two months away, but the ghost stories just keep on coming. The latest version was reported by the Associated Press ...
Another Haunting Tale
Rating: 4.5
Diposkan Oleh:
Unknown
Wednesday, August 19, 2009
High Costs and Poor Outcomes - A Lesson About the Suppression of Research
Last week, blogger Alison Bass was one of the few to comment on a new article on the risks of antidepressant medications published electron...
High Costs and Poor Outcomes - A Lesson About the Suppression of Research
Rating: 4.5
Diposkan Oleh:
Unknown
Subscribe to:
Posts (Atom)